Dynamic changes in 5-hydroxymethylation signatures underpin early and late events in drug exposed liver

Nucleic Acids Research

Volumn 41, Issue 11, 2013, Pages 5639-5654

  Thomson, John P ^a,b   Hunter, Jennifer M ^a   Lempiäinen, Harri ^b,c   Müller, Arne ^b,c   Terranova, Rémi ^b,c   Moggs, Jonathan G ^b,c   Meehan, Richard R ^a,b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b MARCAR Consortium ^*  (United Kingdom)

^c NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYMETHYLCYTOSINE; 5 METHYLCYTOSINE; BIOLOGICAL MARKER; PHENOBARBITAL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEMETHYLATION; DNA METHYLATION; DRUG EXPOSURE; GENE EXPRESSION; GENETIC TRANSCRIPTION; LIVER CANCER; LIVER CARCINOGENESIS; LIVER DEVELOPMENT; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION;

5-METHYLCYTOSINE; ANIMALS; CARCINOGENS; CELL TRANSFORMATION, NEOPLASTIC; CYTOCHROME P-450 ENZYME SYSTEM; CYTOSINE; DNA METHYLATION; EPIGENESIS, GENETIC; GENETIC MARKERS; LIVER; MALE; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOBARBITAL; PROMOTER REGIONS, GENETIC; TRANSCRIPTOME;

RODENTIA;

EID: 84878843769     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkt232     Document Type: Article

References (80)

1. Bird, A. (2002) DNA methylation patterns and epigenetic memory. Genes Dev., 16, 6-21.
2. Wu, H. and Zhang, Y. (2011) Mechanisms and functions of Tet protein-mediated 5-methylcytosine oxidation. Genes Dev., 25, 2436-2452.
3. Hackett, J.A., Reddington, J.P., Nestor, C.E., Dunican, D.S., Branco, M.R., Reichmann, J., Reik, W., Surani, M.A., Adams, I.R. and Meehan, R.R. (2012) Promoter DNA methylation couples genome-defence mechanisms to epigenetic reprogramming in the mouse germline. Development, 139, 3623-3632.
4. Wu, H., D'Alessio, A.C., Ito, S., Wang, Z., Cui, K., Zhao, K., Sun, Y.E. and Zhang, Y. (2011) Genome-wide analysis of 5-hydroxymethylcytosine distribution reveals its dual function in transcriptional regulation in mouse embryonic stem cells. Genes Dev., 25, 679-684.
5. Wu, H., D'Alessio, A.C., Ito, S., Xia, K., Wang, Z., Cui, K., Zhao, K., Eve Sun, Y. and Zhang, Y. (2011) Dual functions of Tet1 in transcriptional regulation in mouse embryonic stem cells. Nature, 473, 389-393.
6. Pastor, W.A., Pape, U.J., Huang, Y., Henderson, H.R., Lister, R., Ko, M., McLoughlin, E.M., Brudno, Y., Mahapatra, S., Kapranov, P. et al. (2011) Genome-wide mapping of 5-hydroxymethylcytosine in embryonic stem cells. Nature, 473, 394-397.
7. Williams, K., Christensen, J., Pedersen, M.T., Johansen, J.V., Cloos, P.A., Rappsilber, J. and Helin, K. (2011) TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity. Nature, 473, 343-348.
8. Stroud, H., Feng, S., Morey Kinney, S., Pradhan, S. and Jacobsen, S.E. (2011) 5-hydroxymethylcytosine is associated with enhancers and gene bodies in human embryonic stem cells. Genome Biol., 12, R54.
9. Xu, Y., Wu, F., Tan, L., Kong, L., Xiong, L., Deng, J., Barbera, A.J., Zheng, L., Zhang, H., Huang, S. et al. (2011) Genome-wide regulation of 5hmC, 5mC, and gene expression by tet1 hydroxylase in mouse embryonic stem cells. Mol. Cell, 42, 451-464.
10. Yu, M., Hon, G.C., Szulwach, K.E., Song, C.X., Zhang, L., Kim, A., Li, X., Dai, Q., Shen, Y., Park, B. et al. (2012) Base-resolution analysis of 5-hydroxymethylcytosine in the mammalian genome. Cell, 149, 1368-1380.
11. Ficz, G., Branco, M.R., Seisenberger, S., Santos, F., Krueger, F., Hore, T.A., Marques, C.J., Andrews, S. and Reik, W. (2011) Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation. Nature, 473, 398-402.
12. Serandour, A.A., Avner, S., Oger, F., Bizot, M., Percevault, F., Lucchetti-Miganeh, C., Palierne, G., Gheeraert, C., Barloy-Hubler, F., Peron, C.L. et al. (2012) Dynamic hydroxymethylation of deoxyribonucleic acid marks differentiation-associated enhancers. Nucleic Acids Res., 40, 8255-8265.
13. Bocker, M.T., Tuorto, F., Raddatz, G., Musch, T., Yang, F.C., Xu, M., Lyko, F. and Breiling, A. (2012) Hydroxylation of 5-methylcytosine by TET2 maintains the active state of the mammalian HOXA cluster. Nat. Commun., 3, 818.
14. Booth, M.J., Branco, M.R., Ficz, G., Oxley, D., Krueger, F., Reik, W. and Balasubramanian, S. (2012) Quantitative sequencing of 5-methylcytosine and 5-hydroxymethylcytosine at single-base resolution. Science, 336, 934-937.
15. Tahiliani, M., Koh, K.P., Shen, Y., Pastor, W.A., Bandukwala, H., Brudno, Y., Agarwal, S., Iyer, L.M., Liu, D.R., Aravind, L. et al. (2009) Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science, 324, 930-935.
16. Nestor, C.E., Ottaviano, R., Reddington, J., Sproul, D., Reinhardt, D., Dunican, D., Katz, E., Dixon, J.M., Harrison, D.J. and Meehan, R.R. (2012) Tissue type is a major modifier of the 5-hydroxymethylcytosine content of human genes. Genome Res., 22, 467-477.
17. Thomson, J.P., Lempiainen, H., Hackett, J.A., Nestor, C.E., Muller, A., Bolognani, F., Oakeley, E.J., Schubeler, D., Terranova, R., Reinhardt, D. et al. (2012) Non-genotoxic carcinogen exposure induces defined changes in the 5-hydroxymethylome. Genome Biol., 13, R93.
18. Song, C.X., Szulwach, K.E., Fu, Y., Dai, Q., Yi, C., Li, X., Li, Y., Chen, C.H., Zhang, W., Jian, X. et al. (2011) Selective chemical labeling reveals the genome-wide distribution of 5-hydroxymethylcytosine. Nat. Biotechnol., 29, 68-72.
19. Ko, M., Huang, Y., Jankowska, A.M., Pape, U.J., Tahiliani, M., Bandukwala, H.S., An, J., Lamperti, E.D., Koh, K.P., Ganetzky, R. et al. (2010) Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2. Nature, 468, 839-843.
20. Koh, K.P., Yabuuchi, A., Rao, S., Huang, Y., Cunniff, K., Nardone, J., Laiho, A., Tahiliani, M., Sommer, C.A., Mostoslavsky, G. et al. (2011) Tet1 and Tet2 regulate 5-hydroxymethylcytosine production and cell lineage specification in mouse embryonic stem cells. Cell Stem Cell, 8, 200-213.
21. Wossidlo, M., Nakamura, T., Lepikhov, K., Marques, C.J., Zakhartchenko, V., Boiani, M., Arand, J., Nakano, T., Reik, W. and Walter, J. (2011) 5-Hydroxymethylcytosine in the mammalian zygote is linked with epigenetic reprogramming. Nat. Commun., 2, 241.
22. Ito, S., D'Alessio, A.C., Taranova, O.V., Hong, K., Sowers, L.C. and Zhang, Y. (2010) Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature, 466, 1129-1133.
23. Ito, S., Shen, L., Dai, Q., Wu, S.C., Collins, L.B., Swenberg, J.A., He, C. and Zhang, Y. (2011) Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science, 333, 1300-1303.
24. Cortellino, S., Xu, J., Sannai, M., Moore, R., Caretti, E., Cigliano, A., Le Coz, M., Devarajan, K., Wessels, A., Soprano, D. et al. (2011) Thymine DNA glycosylase is essential for active DNA demethylation by linked deamination-base excision repair. Cell, 146, 67-79.
25. He, Y.F., Li, B.Z., Li, Z., Liu, P., Wang, Y., Tang, Q., Ding, J., Jia, Y., Chen, Z., Li, L. et al. (2011) Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science, 333, 1303-1307.
26. Inoue, A., Shen, L., Dai, Q., He, C. and Zhang, Y. (2011) Generation and replication-dependent dilution of 5fC and 5caC during mouse preimplantation development. Cell Res., 21, 1670-1676.
27. Inoue, A. and Zhang, Y. (2011) Replication-dependent loss of 5-hydroxymethylcytosine in mouse preimplantation embryos. Science, 334, 194.
28. Hackett, J.A., Sengupta, R., Zylicz, J.J., Murakami, K., Lee, C., Down, T.A. and Surani, M.A. (2012) Germline DNA demethylation dynamics and imprint erasure through 5-hydroxymethylcytosine. Science, 339, 448-452.
29. Seisenberger, S., Andrews, S., Krueger, F., Arand, J., Walter, J., Santos, F., Popp, C., Thienpont, B., Dean, W. and Reik, W. (2012) The dynamics of genome-wide DNA methylation reprogramming in mouse primordial germ cells. Mol. Cell, 48, 849-862.
30. Lian, C.G., Xu, Y., Ceol, C., Wu, F., Larson, A., Dresser, K., Xu, W., Tan, L., Hu, Y., Zhan, Q. et al. (2012) Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma. Cell, 150, 1135-1146.
31. Moran-Crusio, K., Reavie, L., Shih, A., Abdel-Wahab, O., Ndiaye-Lobry, D., Lobry, C., Figueroa, M.E., Vasanthakumar, A., Patel, J., Zhao, X. et al. (2011) Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation. Cancer Cell, 20, 11-24.
32. Figueroa, M.E., Abdel-Wahab, O., Lu, C., Ward, P.S., Patel, J., Shih, A., Li, Y., Bhagwat, N., Vasanthakumar, A., Fernandez, H.F. et al. (2010) Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell, 18, 553-567.
33. Kallin, E.M., Rodriguez-Ubreva, J., Christensen, J., Cimmino, L., Aifantis, I., Helin, K., Ballestar, E. and Graf, T. (2012) Tet2 facilitates the derepression of myeloid target genes during cebpalpha-induced transdifferentiation of pre-B cells. Mol. Cell, 48, 266-276.
34. Lempiainen, H., Muller, A., Brasa, S., Teo, S.S., Roloff, T.C., Morawiec, L., Zamurovic, N., Vicart, A., Funhoff, E., Couttet, P. et al. (2011) Phenobarbital mediates an epigenetic switch at the constitutive androstane receptor (CAR) target gene Cyp2b10 in the liver of B6C3F1 mice. PLoS One, 6, e18216.
35. Phillips, J.M., Yamamoto, Y., Negishi, M., Maronpot, R.R. and Goodman, J.I. (2007) Orphan nuclear receptor constitutive active/androstane receptor-mediated alterations in DNA methylation during phenobarbital promotion of liver tumorigenesis. Toxicol. Sci., 96, 72-82.
36. Watson, R.E. and Goodman, J.I. (2002) Epigenetics and DNA methylation come of age in toxicology. Toxicol. Sci., 67, 11-16.
37. Thomson, J.P., Lempiainen, H., Hackett, J., Nestor, C., Muller, A., Bolognani, F., Oakeley, E.J., Schubeler, D., Terranova, R., Reinhardt, D. et al. (2012) Non-genotoxic carcinogen exposure induces defined changes in the 5-hydroxymethylome. Genome Biol., 13, R93.
38. Loeppen, S., Schneider, D., Gaunitz, F., Gebhardt, R., Kurek, R., Buchmann, A. and Schwarz, M. (2002) Overexpression of glutamine synthetase is associated with beta-catenin-mutations in mouse liver tumors during promotion of hepatocarcinogenesis by phenobarbital. Cancer Res., 62, 5685-5688.
39. Rencurel, F., Stenhouse, A., Hawley, S.A., Friedberg, T., Hardie, D.G., Sutherland, C. and Wolf, C.R. (2005) AMP-activated protein kinase mediates phenobarbital induction of CYP2B gene expression in hepatocytes and a newly derived human hepatoma cell line. J. Biol. Chem., 280, 4367-4373.
40. Cheng, A.S., Lau, S.S., Chen, Y., Kondo, Y., Li, M.S., Feng, H., Ching, A.K., Cheung, K.F., Wong, H.K., Tong, J.H. et al. (2011) EZH2-mediated concordant repression of Wnt antagonists promotes beta-catenin-dependent hepatocarcinogenesis. Cancer Res., 71, 4028-4039.
41. Luk, J.M., Burchard, J., Zhang, C., Liu, A.M., Wong, K.F., Shek, F.H., Lee, N.P., Fan, S.T., Poon, R.T., Ivanovska, I. et al. (2011) DLK1-DIO3 genomic imprinted microRNA cluster at 14q32.2 defines a stemlike subtype of hepatocellular carcinoma associated with poor survival. J. Biol. Chem., 286, 30706-30713.
42. Monnier, J., Boissan, M., L'Helgoualc'h, A., Lacombe, M.L., Turlin, B., Zucman-Rossi, J., Theret, N., Piquet-Pellorce, C. and Samson, M. (2012) CXCR7 is up-regulated in human and murine hepatocellular carcinoma and is specifically expressed by endothelial cells. Eur. J. Cancer, 48, 138-148.
43. Smyth, G.K. (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol., 3, Article3.
44. Bolstad, B.M., Irizarry, R.A., Astrand, M. and Speed, T.P. (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics, 19, 185-193.
45. Shen, Y., Yue, F., McCleary, D.F., Ye, Z., Edsall, L., Kuan, S., Wagner, U., Dixon, J., Lee, L., Lobanenkov, V.V. et al. (2012) A map of the cis-regulatory sequences in the mouse genome. Nature, 488, 116-120.
46. Weber, M., Hellmann, I., Stadler, M.B., Ramos, L., Paabo, S., Rebhan, M. and Schubeler, D. (2007) Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat. Genet., 39, 457-466.
47. Seifert, M., Cortijo, S., Colome-Tatche, M., Johannes, F., Roudier, F. and Colot, V. (2012) MeDIP-HMM: genome-wide identification of distinct DNA methylation states from high-density tiling arrays. Bioinformatics, 28, 2930-2939.
48. Down, T.A., Rakyan, V.K., Turner, D.J., Flicek, P., Li, H., Kulesha, E., Graf, S., Johnson, N., Herrero, J., Tomazou, E.M. et al. (2008) A Bayesian deconvolution strategy for immunoprecipitation-based DNA methylome analysis. Nat. Biotechnol., 26, 779-785.
49. Nair, S.S., Coolen, M.W., Stirzaker, C., Song, J.Z., Statham, A.L., Strbenac, D., Robinson, M.D. and Clark, S.J. (2011) Comparison of methyl-DNA immunoprecipitation (MeDIP) and methyl-CpG binding domain (MBD) protein capture for genome-wide DNA methylation analysis reveal CpG sequence coverage bias. Epigenetics, 6, 34-44.
50. Sasaki, K. and Sonoda, Y. (2000) Histometrical and threedimensional analyses of liver hematopoiesis in the mouse embryo. Arch. Histol. Cytol., 63, 137-146.
51. Apte, U., Zeng, G., Thompson, M.D., Muller, P., Micsenyi, A., Cieply, B., Kaestner, K.H. and Monga, S.P. (2007) beta-Catenin is critical for early postnatal liver growth. Am. J. Physiol. Gastrointest. Liver Physiol., 292, G1578-G1585.
52. Otu, H.H., Naxerova, K., Ho, K., Can, H., Nesbitt, N., Libermann, T.A. and Karp, S.J. (2007) Restoration of liver mass after injury requires proliferative and not embryonic transcriptional patterns. J. Biol. Chem., 282, 11197-11204.
53. Lempiainen, H., Couttet, P., Bolognani, F., Muller, A., Dubost, V., Luisier, R., Del Rio Espinola, A., Vitry, V., Unterberger, E., Thomson, J.P. et al. (2013) Identification of Dlk1-Dio3 imprinted gene cluster non-coding RNAs as novel candidate biomarkers for liver tumor promotion. Toxicol. Sci., 131, 375-386.
54. Aydinlik, H., Nguyen, T.D., Moennikes, O., Buchmann, A. and Schwarz, M. (2001) Selective pressure during tumor promotion by phenobarbital leads to clonal outgrowth of beta-catenin-mutated mouse liver tumors. Oncogene, 20, 7812-7816.
55. Huang, Y., Pastor, W.A., Shen, Y., Tahiliani, M., Liu, D.R. and Rao, A. (2010) The behaviour of 5-hydroxymethylcytosine in bisulfite sequencing. PLoS One, 5, e8888.
56. Song, C.X., Yi, C. and He, C. (2012) Mapping recently identified nucleotide variants in the genome and transcriptome. Nat. Biotechnol., 30, 1107-1116.
57. Jin, S.G., Wu, X., Li, A.X. and Pfeifer, G.P. (2011) Genomic mapping of 5-hydroxymethylcytosine in the human brain. Nucleic Acids Res., 39, 5015-5024.
58. Nestor, C., Ottaviano, R., Reinhardt, D., Sproul, D., Dunican, D.S., Reddingtion, J.P., Katz, E., Dixon, M., Harrison, D.J. and Meehan, R. (2011) Tissue-type is a major modifier of the 5-hydroxymethylcytosine content of human genes. Genome Res., 22, 467-477.
59. Kriaucionis, S. and Heintz, N. (2009) The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science, 324, 929-930.
60. Liu, L., Luo, G.Z., Yang, W., Zhao, X., Zheng, Q., Lv, Z., Li, W., Wu, H.J., Wang, L., Wang, X.J. et al. (2010) Activation of the imprinted Dlk1-Dio3 region correlates with pluripotency levels of mouse stem cells. J. Biol. Chem., 285, 19483-19490.
61. Stadtfeld, M., Apostolou, E., Akutsu, H., Fukuda, A., Follett, P., Natesan, S., Kono, T., Shioda, T. and Hochedlinger, K. (2010) Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells. Nature, 465, 175-181.
62. Phillips, J.M., Burgoon, L.D. and Goodman, J.I. (2009) The constitutive active/androstane receptor facilitates unique phenobarbital-induced expression changes of genes involved in key pathways in precancerous liver and liver tumors. Toxicol. Sci., 110, 319-333.
63. Phillips, J.M., Burgoon, L.D. and Goodman, J.I. (2009) Phenobarbital elicits unique, early changes in the expression of hepatic genes that affect critical pathways in tumor-prone B6C3F1 mice. Toxicol. Sci., 109, 193-205.
64. Calvisi, D.F., Ladu, S., Factor, V.M. and Thorgeirsson, S.S. (2004) Activation of beta-catenin provides proliferative and invasive advantages in c-myc/TGF-alpha hepatocarcinogenesis promoted by phenobarbital. Carcinogenesis, 25, 901-908.
65. Chua, M.S., Sun, H., Cheung, S.T., Mason, V., Higgins, J., Ross, D.T., Fan, S.T. and So, S. (2007) Overexpression of NDRG1 is an indicator of poor prognosis in hepatocellular carcinoma. Mod. Pathol., 20, 76-83.
66. Yamamoto, Y., Moore, R., Goldsworthy, T.L., Negishi, M. and Maronpot, R.R. (2004) The orphan nuclear receptor constitutive active/androstane receptor is essential for liver tumor promotion by phenobarbital in mice. Cancer Res., 64, 7197-7200.
67. Holsapple, M.P., Pitot, H.C., Cohen, S.M., Boobis, A.R., Klaunig, J.E., Pastoor, T., Dellarco, V.L. and Dragan, Y.P. (2006) Mode of action in relevance of rodent liver tumors to human cancer risk. Toxicol. Sci., 89, 51-56.
68. Honkakoski, P., Zelko, I., Sueyoshi, T. and Negishi, M. (1998) The nuclear orphan receptor CAR-retinoid X receptor heterodimer activates the phenobarbital-responsive enhancer module of the CYP2B gene. Mol. Cell. Biol., 18, 5652-5658.
69. Kawamoto, T., Kakizaki, S., Yoshinari, K. and Negishi, M. (2000) Estrogen activation of the nuclear orphan receptor CAR (constitutive active receptor) in induction of the mouse Cyp2b10 gene. Mol. Endocrinol., 14, 1897-1905.
70. Konno, Y., Kamino, H., Moore, R., Lih, F., Tomer, K.B., Zeldin, D.C., Goldstein, J.A. and Negishi, M. (2010) The nuclear receptors constitutive active/androstane receptor and pregnane x receptor activate the Cyp2c55 gene in mouse liver. Drug Metab. Dispos., 38, 1177-1182.
71. Guengerich, F.P. (2008) Cytochrome p450 and chemical toxicology. Chem. Res. Toxicol., 21, 70-83.
72. Hayes, J.D., Flanagan, J.U. and Jowsey, I.R. (2005) Glutathione transferases. Annu. Rev. Pharmacol. Toxicol., 45, 51-88.
73. Xie, H.J., Yasar, U., Lundgren, S., Griskevicius, L., Terelius, Y., Hassan, M. and Rane, A. (2003) Role of polymorphic human CYP2B6 in cyclophosphamide bioactivation. Pharmacogenomics J., 3, 53-61.
74. Hoflack, J.C., Mueller, L., Fowler, S., Braendli-Baiocco, A., Flint, N., Kuhlmann, O., Singer, T. and Roth, A. (2012) Monitoring Cyp2b10 mRNA expression at cessation of 2-year carcinogenesis bioassay in mouse liver provides evidence for a carcinogenic mechanism devoid of human relevance: the dalcetrapib experience. Toxicol. Appl. Pharmacol., 259, 355-365.
75. Lahousse, S.A., Hoenerhoff, M., Collins, J., Ton, T.V., Masinde, T., Olson, D., Rebolloso, Y., Koujitani, T., Tomer, K.B., Hong, H.H. et al. (2011) Gene expression and mutation assessment provide clues of genetic and epigenetic mechanisms in liver tumors of oxazepam-exposed mice. Vet. Pathol., 48, 875-884.
76. Anwar, S.L., Krech, T., Hasemeier, B., Schipper, E., Schweitzer, N., Vogel, A., Kreipe, H. and Lehmann, U. (2012) Loss of imprinting and allelic switching at the DLK1-MEG3 locus in human hepatocellular carcinoma. PLoS One, 7, e49462.
77. Jelinic, P. and Shaw, P. (2007) Loss of imprinting and cancer. J. Pathol., 211, 261-268.
78. Wei, W., Chua, M.S., Grepper, S. and So, S.K. (2009) Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cells. Mol. Cancer, 8, 76.
79. Wei, P., Zhang, J., Egan-Hafley, M., Liang, S. and Moore, D.D. (2000) The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism. Nature, 407, 920-923.
80. Pastor, W.A., Pape, U.J., Huang, Y., Henderson, H.R., Lister, R., Ko, M., McLoughlin, E.M., Brudno, Y., Mahapatra, S., Kapranov, P. et al. (2011) Genome-wide mapping of 5-hydroxymethylcytosine in embryonic stem cells. Nature, 473, 394-397.